Stefano Gitto Selected Research

Surgical Portasystemic Shunt (Portosystemic Shunt)

1/2023	Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
1/2023	Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients.
1/2022	Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.
1/2021	Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
1/2020	Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.
1/2019	Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Gitto Research Topics

Disease

15	Fibrosis (Cirrhosis) 02/2024 - 08/2010
9	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2012
8	Liver Diseases (Liver Disease) 04/2022 - 11/2011
7	Non-alcoholic Fatty Liver Disease 08/2021 - 02/2013
6	Neoplasms (Cancer) 03/2024 - 01/2018
6	Portal Hypertension 10/2023 - 01/2019
6	Chronic Hepatitis C 11/2021 - 02/2012
5	End Stage Liver Disease 02/2024 - 06/2011
5	Hemorrhage 01/2023 - 01/2018
5	Ascites 01/2023 - 01/2015
5	Hepatitis C 01/2017 - 02/2013
4	Thrombosis (Thrombus) 01/2021 - 11/2012
4	Hepatitis B 01/2019 - 12/2014
3	Infections 01/2023 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2018
3	Hepatic Encephalopathy 01/2021 - 01/2018
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020 - 01/2010
3	Hepatitis 01/2020 - 04/2011
3	Fatty Liver 01/2018 - 04/2016
2	Hypertension (High Blood Pressure) 02/2024 - 06/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2024
2	Acute Liver Failure (Fulminant Hepatic Failure) 02/2024 - 04/2016
2	Alcoholic Fatty Liver 02/2024 - 06/2016
2	Liver Neoplasms (Liver Cancer) 08/2022 - 01/2019
2	Inflammation (Inflammations) 08/2022 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2022 - 11/2021
2	Weight Gain 01/2021 - 01/2020
2	Chronic Hepatitis B 01/2019 - 04/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2016
2	Insulin Resistance 01/2018 - 04/2016
2	Body Weight (Weight, Body) 01/2018 - 04/2016
1	Skin Neoplasms (Skin Cancer) 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 04/2022
1	COVID-19 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Frailty 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Disease Progression 08/2020
1	Heart Failure 01/2020
1	Alcoholism (Alcohol Abuse) 01/2020
1	Cholelithiasis 01/2019
1	Intrahepatic Cholestasis 01/2019
1	Cholestasis 01/2019
1	Intrahepatic Cholestasis of Pregnancy 01/2019
1	progressive familial intrahepatic 1 Cholestasis 08/2018
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2018
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2018
1	Varicose Veins (Varicose Vein) 01/2018

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 11/2021 - 04/2011
3	LipidsIBA 02/2018 - 04/2011
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2024 - 06/2016
2	InterferonsIBA 11/2021 - 04/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2019
2	AlbuminsIBA 01/2019 - 01/2015
2	BilirubinIBA 01/2019 - 01/2015
2	Bile Acids and Salts (Bile Acids)IBA 02/2018 - 02/2018
2	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 01/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2018 - 11/2012
2	SodiumIBA 01/2015 - 08/2010
2	Estrogens (Estrogen)FDA Link 02/2013 - 01/2012
1	Everolimus FDA Link 03/2024
1	Propranolol (Inderal)FDA LinkGeneric 10/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023
1	Oncostatin MIBA 08/2022
1	CytokinesIBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	Monoclonal AntibodiesIBA 04/2022
1	Angiopoietin-2IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 03/2021
1	Metalloproteases (Metalloproteinases)IBA 03/2021
1	PlasminogenIBA 03/2021
1	fibrin fragment D (D-dimer)IBA 03/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2021
1	GelatinasesIBA 03/2021
1	FibrinIBA 08/2020
1	Fibrinogen (Factor I)FDA Link 08/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Hepatitis B e AntigensIBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Adenosine Triphosphate (ATP)IBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	Amino Acids FDA Link 02/2018
1	obeticholic acidIBA 02/2018
1	CreatinineIBA 01/2018
1	EnzymesIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	HDL LipoproteinsIBA 01/2018

Therapy/Procedure

25	Liver Transplantation 03/2024 - 01/2010
9	Therapeutics 11/2021 - 04/2011
6	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 01/2019
5	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 01/2018
5	Transplantation 01/2022 - 02/2013
1	Radiofrequency Ablation 07/2022
1	Biological Therapy 04/2022
1	Contraindications 01/2020
1	Stents 01/2018
1	Ligation 01/2018